Loading…
← CockpitCompetitor Analysis › 300758.SZ Anshan Hifichem Co., Ltd. Class AOpen in the cockpit ↗

Anshan Hifichem Co., Ltd. Class A300758.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Specialty
Momentum strong 61
Mkt cap
$615M
US dollars, full cap
Free float
69%
of shares outstanding
$/day
$16.1M
20-day average traded
Fwd P/E
45.2×
forward earnings
ROIC−WACC
-2.8 pp
WACC 10.3%
Hurdle
+7 pp
Req g minus delivered
Next earnings
173 days
28 Apr 2027
Close · CNYCN¥10.39
1D-1.5%
1W+3.5%
1M-10.0%
3M+2.3%
6M-22.0%
YTD-18.1%
1Y-23.8%
ATR %4.8%
52w lowhigh51.9% off high

What Anshan Hifichem does

Employees: 2,241

Anshan Hifichem at a glance

Size Anshan Hifichem (300758.SZ) is a China Materials company (Chemicals: Specialty) with a market value of $615M, the 3364th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥10.39 on 6 Nov 2026.

Performance Over six months the shares fell 22.0%, against -16.5% for the median peer and -16.4% for the China market (cap-weighted) — 10th lowest of 21 in its peer set.

Growth Revenue grew 11.5% over the last twelve months (peer median +11.1%); the operating margin is 9.3% (peer median 5.5%).

Valuation It trades at 45.2× forward earnings against a peer median of 13.2× (most expensive of 9).

Price implies For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +7 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 2.8 points below its cost of capital (10.3% WACC).

Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026Peer median 82300758.SZ 74
Six months, rebased to 100: Anshan Hifichem against the median of its 20 peers (local-currency closes).

Anshan Hifichem financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.70BCN¥1.49BCN¥1.56BCN¥1.21BCN¥1.20B
Revenue growth—-5%+29%+1%—
Gross profitCN¥642MCN¥420MCN¥479MCN¥274MCN¥281M
EBITDAn/aCN¥304MCN¥358MCN¥185MCN¥141M
Net incomeCN¥83.5MCN¥61.2MCN¥125MCN¥11.0M-CN¥2.79M
Free cash flowCN¥106M-CN¥87.3MCN¥69.1M-CN¥161M-CN¥95.0M
Capital expenditureCN¥55.8MCN¥162MCN¥75.8MCN¥165MCN¥192M
Total debtCN¥1.22BCN¥1.32BCN¥1.19BCN¥1.06BCN¥1.08B

Quarterly statements and history in the cockpit →

Anshan Hifichem competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%-10%0%6037906881961709002637BALAMINES4770801430047800258430084800400040280008196032763015576030511711301246002805301538300758.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Anshan Hifichem is the large dot.

Fundamentals: revenue growth against valuation

-10%0%+10%+20%20×40×688196002637BALAMINES47703008480040004028301538300758.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Anshan Hifichem is the large dot.

Capital: growth delivered against growth the price implies

0%+20%0%20%6037901709002637477080143004780040004028603276603051301538300758.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Anshan Hifichem is the large dot.

Anshan Hifichem competitors and peer comparison

How Anshan Hifichem compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Anshan Hifichem against its 20 peers (data as of 6 Nov 2026)
Measure300758.SZPeer medianRank in peer set
1-month return-10.0%-10.0%11th highest of 21
6-month return-22.0%-16.5%10th lowest of 21
Distance from 52-week high-51.9%-40.2%7th lowest of 21
Revenue growth (TTM)+11.5%+11.1%11th highest of 21
Operating margin9.3%5.5%8th highest of 21
Forward P/E45.2×13.2×most expensive of 9
Growth the price implies (Req g, 7 yrs)15.5%3.4%4th most demanding of 12
Growth delivered (Del g)+8.2%+8.5%6th lowest of 12
Hurdle (Req g minus delivered)+7.3 pp-7.7 pp4th most demanding of 12
ROIC minus cost of capital-2.8 pp-1.9 pp10th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Anshan Hifichem 300758.SZChina$615M-22%+11%9%45.2×15.5%+8.2%
Argus (Shanghai) Textile Chemicals 603790.SSChina$618M-11%+21%14%n/a11.7%+0.7%
Longyan Zhuoyue New Energy 688196.SSChina$622M-38%+2%1%35.0×n/an/a
Formosan Union Chemical 1709.TWTaiwan$607M+128%-3%14%n/a-1.6%+1.2%
Zanyu Technology 002637.SZChina$605M-34%-3%3%9.3×-0.9%+11.0%
Balaji Amines BALAMINES.NSIndia$604M+15%+21%19%36.2×n/an/a
Allied Supreme 4770.TWTaiwan$629M+12%-15%19%14.2×3.4%+12.4%
Chori 8014.TJapan$629M-6%+3%4%n/a-13.4%+6.7%
Hangzhou Gaoxin Materials Technology 300478.SZChina$631M+11%-21%-9%n/a30.8%-0.9%
Xilong Scientific 002584.SZChina$632M-11%+23%1%n/an/an/a
Miracll Chemicals 300848.SZChina$632M-45%+23%1%12.2×n/an/a
LOTTE Fine Chem 004000.KSSouth Korea$634M-51%+18%7%4.5×-8.2%+6.8%
Ishihara Sangyo Kaisha 4028.TJapan$596M-22%+1%11%9.5×1.1%+8.8%
Yueyang Xingchang Petro-Chemical 000819.SZChina$636M-29%+44%1%n/an/an/a
Jiangsu Hengxing New Material Technology 603276.SSChina$596M+7%+29%8%n/a18.5%+15.2%
Cytech 301557.SZChina$595M-3%+13%7%n/an/an/a
Guangzhou Lushan New Materials 603051.SSChina$595M+5%-5%0%n/a32.5%+8.5%
Everlight Chemical Industrial 1711.TWTaiwan$593M-45%-2%-1%n/an/an/a
Hubei Hongyuan Pharmaceutical Technology 301246.SZChina$639M-47%+45%12%n/an/an/a
Shandong Fengyuan Chemical 002805.SZChina$591M-38%+281%1%n/an/an/a
Shenzhen Jdd Tech New Material 301538.SZChina$591M-33%+10%18%14.6×15.3%+25.6%

Questions

Which companies are Anshan Hifichem's closest peers?
The cockpit's peer set: Argus (Shanghai) Textile Chemicals (603790.SS), Longyan Zhuoyue New Energy (688196.SS), Formosan Union Chemical (1709.TW), Zanyu Technology (002637.SZ), Balaji Amines (BALAMINES.NS), Allied Supreme (4770.TW), Chori (8014.T), Hangzhou Gaoxin Materials Technology (300478.SZ).
Is Anshan Hifichem expensive compared with its peers?
On forward p/e it trades at 45.2× against a peer median of 13.2×, most expensive of 9 in its peer set. For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +7 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Anshan Hifichem stock performed?
Over six months to 6 Nov 2026 the shares returned -22.0% against -16.5% for the median peer; over one year -23.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.